Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Intravitreal Corticosteroids: Ensuring Effective Use With IOP Control

By: Michael A. Singer, MD, moderator; Maria H. Berrocal, MD; Tarek S. Hassan, MD; Andrew A. Moshfeghi, MD, MBA; Gaurav K. Shah, MD

This course has expired. You can still review the content but course credit is no longer available.

Supplement Credits: 1

This continuing medical education (CME) activity captures content from a roundtable discussion held in May of 2016 in Seattle, Washington.

Expiration Date: Tuesday, October 31, 2017
Release Date: October 2016

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Identify risk factors associated with rises in IOP after steroid use
  • Discuss management strategies for patients who experience rises in IOP after steroid use
  • Assess clinical trial data pertaining to steroid implant therapies, including MEAD, FAME, BEVORDEX and OMAR

Accreditation and Designation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC, Retina Today, and New Retina MD. Evolve Medical Education LLC is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosures

Michael A. Singer, MD, moderator
Medical Center Ophthalmology Associates
San Antonio, Texas

Maria H. Berrocal, MD
Berrocal & Associates
San Juan, Puerto Rico

Tarek S. Hassan, MD
Associated Retinal Consultants
Royal Oak, Michigan

Andrew A. Moshfeghi, MD, MBA
Keck School of Medicine
Los Angeles, California

Gaurav K. Shah, MD
The Retina Institute
St. Louis, Missouri

It is the policy of Evolve Medical Education LLC that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve Medical Education LLC has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Michael A. Singer, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan; Genentech; and Regeneron Pharmaceuticals. Grant/Research Support: Aerpio Therapeutics; Allergan; Ampio Pharmaceuticals; Genentech; Ohr Pharmaceutical; and Regeneron Pharmaceuticals.

Maria H. Berrocal, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon; Alimera Sciences; and Allergan. Stock/Shareholder: Hemera.

Tarek S. Hassan, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan, Bausch + Lomb; Eyetech Pharmaceuticals; Genentech; Insight Instruments; Regeneron Pharmaceuticals; and ThromboGenics NV. Patent Holder: Insight Instruments. Stock/Shareholder: ArcticDx and OptiMedica.

Andrew A. Moshfeghi, MD, MBA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; Genentech; and Regeneron Pharmaceuticals. Grant/Research Support: Genentech and Regeneron Pharmaceuticals.

Gaurav K. Shah, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan; Bausch + Lomb; QLT; Regeneron Pharmaceuticals.

Cheryl Cavanaugh, MS, director of operations, Evolve Medical Education LLC; Emily Feinman, administrator, BMC; Bryan Bechtel, writer; and Melanie Lawler, PhD, reviewer, have no financial relationships with commercial interests.

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC, New Retina MD, Retina Today, or Allergan.

OFF-LABEL STATEMENT

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Intravitreal Corticosteroids: Ensuring Effective Use With IOP Control

Michael A. Singer, MD, moderator; Maria H. Berrocal, MD; Tarek S. Hassan, MD; Andrew A. Moshfeghi, MD, MBA; Gaurav K. Shah, MD

BackNext